4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-19-054401
Options or other derivatives
- Director acquired 94,031 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Bowden Christopher Director | 2019-10-25 | Grant or award · Stock Option (right to buy) | +94,031 | 94,031 | D | ||
Loading xslF345X03/doc4.xml…